Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
Public ClinicalTrials.gov record NCT06282458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Dose-Finding and Proof-of-Concept Study to Evaluate the Effect on Body Composition and Safety of Enobosarm in Patients Treated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Chronic Weight Management
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 receptor agonists.
Study identification
- NCT ID
- NCT06282458
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2024
- Primary completion
- Apr 10, 2025
- Completion
- Aug 21, 2025
- Last update posted
- Sep 16, 2025
2024 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Trials | Anniston | Alabama | 36207 | — |
| Cullman Clinical Trials | Cullman | Alabama | 35055 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Universal Axom Clinical Research | Doral | Florida | 33122 | — |
| Altus Research | Lake Worth | Florida | 33461 | — |
| MARC Research Center | Louisville | Kentucky | 40213 | — |
| Pennington Biomedical | Baton Rouge | Louisiana | 70810 | — |
| DelRicht Research - New Orleans | New Orleans | Louisiana | 70115 | — |
| Centennial Medical Group (CMG) | Elkridge | Maryland | 21075 | — |
| SKY Integrative Medical Center | Ridgeland | Mississippi | 39157 | — |
| Clinvest Headlands LLC | Springfield | Missouri | 65807 | — |
| Palm Research Center | Las Vegas | Nevada | 89119 | — |
| Lillestol Research LLC | Fargo | North Dakota | 58104 | — |
| Clinical Trials of Texas, LLC DBA Flourish Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06282458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2025 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06282458 live on ClinicalTrials.gov.